| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |